Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain

Int Clin Psychopharmacol. 2003 Mar;18(2):113-5. doi: 10.1097/00004850-200303000-00009.

Abstract

Weight gain with atypical antipsychotics such as clozapine has been hypothesized to have a multifactorial genesis. Beside changes in neurotransmitter systems caused by antipsychotic-induced receptor blockade, hormonal changes and other neuroleptic side-effects (sedation, reduced activity, reduced basal metabolic rate, dry mouth) are also discussed. Our unique case report of a patient with comorbid galactosemia and schizophrenia is an interesting example of weight gain being a positive side-effect of clozapine, not necessarily associated with increased appetite and higher caloric intake.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Clozapine / adverse effects
  • Clozapine / therapeutic use*
  • Galactosemias / complications
  • Galactosemias / drug therapy*
  • Galactosemias / physiopathology
  • Humans
  • Male
  • Schizophrenia / complications
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology
  • Weight Gain*

Substances

  • Antipsychotic Agents
  • Clozapine